Kevin Hern: “Any restriction on our ability to mine these materials would hamper our industries and their growth, and make us reliant…”

One way to do this is by reducing the regulatory burden so that Title IV-B funding recipients can spend more time helping children and families, and less time waiting through the red tape.

The so-called Inflation Reduction Act is only making it worse.

It is sad that what we are dealing with is stifled innovation and a decrease in patient access due to the Inflation Reduction Act.

I will always advocate for those who are suffering from a rare disease and support efforts to bring treatments for these diseases to market.